CurrentEndo
Get Weekly

CurrentEndo coverage · page 18 of 55

Diabetes, Obesity and Metabolism

Briefs 681–720 of 2,200 CurrentEndo has covered from this journal, newest publication first

Latest from Diabetes, Obesity and Metabolism

All coverage, newest first

  1. Diabetes Obes Metab

    Population‐based cohort validation and replication reveals limited generalizability of cluster‐based MASLD subtypes

    Cohort studyLipids & liver

  2. Diabetes Obes Metab

    Efficacy, tolerability, and safety of Efsubaglutide Alfa in participants with obesity or overweight ( LIGHT 1): A randomized, double‐blind, placebo‐controlled, ascending‐dose phase 2a trial

    Randomized controlled trialObesity

  3. Diabetes Obes Metab

    Once‐weekly insulin icodec versus once‐daily insulin degludec for type 2 diabetes in China: A cost‐utility and budget impact analysis

    Cohort studyT2D & other

  4. Diabetes Obes Metab

    Associations between anthropometric measures of obesity and prediabetes risk: A dose–response meta‐analysis of cohort studies

    Meta-analysisT2D & other

  5. Diabetes Obes Metab

    Comparison of DXA , BIA , and anthropometry for assessing subcutaneous, visceral, liver, and pancreas fat measured by MRI

    Cross-sectional study

  6. Diabetes Obes Metab

    Dual action of imeglimin on insulin secretion and sensitivity in type 2 diabetes

    Research articleT2D & other

  7. Diabetes Obes Metab

    Effects of age and disease duration on the glycaemic outcomes and safety of insulin glargine 300 U/ mL in people with type 2 diabetes in China: A post‐hoc analysis of the INITIATION study

    Secondary analysisT2D & other

  8. Diabetes Obes Metab

    Increasing cardiovascular mortality in young adults with diabetes mellitus as a contributing cause in the United States

    Cross-sectional studyT2D & other

  9. Diabetes Obes Metab

    Mental health changes after 4 months of weight loss treatment with the glucagon‐like peptide‐1 analogue liraglutide 3.0 mg

    Cohort studyObesity

  10. Diabetes Obes Metab

    Oral semaglutide and survival in heart failure with preserved ejection fraction and type 2 diabetes

    Cohort studyT2D & other

  11. Diabetes Obes Metab

    Semaglutide and tirzepatide effects on cardiovascular outcomes in people with overweight or obesity in the real world ( STEER )

    Cohort studyObesity

  12. Diabetes Obes Metab

    The importance of treatment sequencing with SGLT2 inhibitors and GLP ‐1 receptor agonists combination for kidney function preservation in type 2 diabetes

    Cohort studyT2D & other

  13. Diabetes Obes Metab

    Age disparities in SGLT2 inhibitor prescription among people with type 2 diabetes: The role of frailty and sex

    Cross-sectional studyT2D & other

  14. Diabetes Obes Metab

    Performance of continuous glucose monitoring systems ( CGMs ) during commercial flights in T1DM: A within‐subject comparative pilot study

    Research articleTechnology

  15. Diabetes Obes Metab

    Precision nutrition in weight loss and neuroendocrine control of people with obesity: The study protocol of a factorial randomised controlled trial ( GenON Programme)

    Trial designObesity

  16. Diabetes Obes Metab

    Obstructive sleep apnea is associated with greater MASH and significant fibrosis severity in patients with obesity: A prospective clinicopathological study

    Cross-sectional studyObesity

  17. Diabetes Obes Metab

    Comparative safety of glucose‐lowering medications on depression in adults with type 2 diabetes

    Cohort studyT2D & other

  18. Diabetes Obes Metab

    Comparative effectiveness of glucose monitoring methods and glycaemic control in patients with type 2 diabetes: An umbrella review

    Randomized controlled trialT2D & other

  19. Diabetes Obes Metab

    Effects of SGLT2 inhibitors on development and progression of kidney disease in Chinese patients with type 2 diabetes: A multicentre, prospective real‐world study

    Cohort studyT2D & other

  20. Diabetes Obes Metab

    Glucose‐dependent insulinotropic polypeptide reduces postprandial glucose excursions but does not protect from hypoglycaemia in persons with type 1 diabetes—A randomised placebo‐controlled study

    Randomized controlled trialT1D

  21. Diabetes Obes Metab

    Risk of diabetic retinopathy and ophthalmic interventions in patients with diabetes mellitus taking different oral anticoagulants

    Cohort studyComplications

  22. Diabetes Obes Metab

    Accuracy and reliability of a continuous glucose monitoring system with a focus on hypoglycaemia

    Diagnostic or prognostic studyTechnology

  23. Diabetes Obes Metab

    Comprehensive risk factor control and its biomarker‐mediated association with diabetic microvascular complications

    Cohort studyT2D & other

  24. Diabetes Obes Metab

    Association between glucagon‐like peptide‐1 receptor agonists and risk of dementia in older adults with type 2 diabetes: A target trial emulation

    Cohort studyT2D & other

  25. Diabetes Obes Metab

    Spatiotemporal burden, risk factors, and genetic causality of non‐alcoholic fatty liver disease and type 2 diabetes mellitus comorbidity in Europe: A multi‐database analysis

    Research article

  26. Diabetes Obes Metab

    In‐flight glycaemic control using automated insulin delivery systems: A within‐subject comparative pilot study

    Research article

  27. Diabetes Obes Metab

    Comparative accuracy of smartphone apps and a generative AI tool for carbohydrate counting: An independent bicentric study

    Diagnostic or prognostic studyT1D

  28. Diabetes Obes Metab

    Obesity and overweight‐related differences in cardiometabolic risk factors in type 1 diabetes

    Cross-sectional studyObesity

  29. Diabetes Obes Metab

    Relationship between cardiometabolic index and worsening renal function in T2DM : Insights from machine learning, growth mixture modelling, and development of a web‐based risk prediction tool

    Secondary analysisComplications

  30. Diabetes Obes Metab

    Impact of glucagon‐like peptide‐1 receptor agonism‐based therapies on limb outcomes in peripheral artery disease and type 2 diabetes: An updated systematic review and meta‐analysis

    Meta-analysis

  31. Diabetes Obes Metab

    Efficacy of a low‐carbohydrate diet combined with exercise on glycemic control and metabolic health in type 2 diabetes mellitus: A systematic review and meta‐analysis

    Meta-analysisT2D & other

  32. Diabetes Obes Metab

    Efficacy and safety of combining empagliflozin in people with type 2 diabetes mellitus uncontrolled with metformin and sitagliptin: A randomised, double‐blind, multicentre, therapeutic confirmatory phase 3 clinical trial

    Randomized controlled trialT2D & other

  33. Diabetes Obes Metab

    Effects of exercise interventions on 24‐h continuous glucose profiles in non‐diabetic populations: A systematic review and meta‐analysis

    Meta-analysisTechnology

  34. Diabetes Obes Metab

    Performance of three simultaneously used rtCGM systems around a physically active weekend camp in adults with type 1 diabetes: A prospective lab and real‐world study

    Diagnostic or prognostic studyTechnology

  35. Diabetes Obes Metab

    Glucose tolerance and mortality across 24 cancer types and stages: A K‐ CURE Nationwide registry study

    Cohort studyT2D & other

  36. Diabetes Obes Metab

    Serum glycated albumin‐to‐albumin ratio and mortality risk in cardiovascular–kidney–metabolic syndrome: Evidence from NHANES over 15 years

    Cohort studyT2D & other

  37. Diabetes Obes Metab

    Ultrasound and MRI abdominal fat distribution and its associations with metabolic conditions in adults with abdominal obesity

    Cross-sectional studyObesity

  38. Diabetes Obes Metab

    Global prevalence of chronic kidney disease in type 1 diabetes: A systematic review and meta‐analysis

    Meta-analysisComplications

  39. Diabetes Obes Metab

    Burden of long‐term conditions and management of people with overweight and obesity: Data from the United Kingdom primary care cohort of the IMPACT ‐O study

    Cohort studyObesity

  40. Diabetes Obes Metab

    Work productivity, associated risk factors and costs on presenteeism and absenteeism in Chinese patients with young‐onset type‐2 diabetes in Hong Kong

    Cross-sectional studyT2D & other

All 2,200 Briefs in ExploreShowing Briefs 681–720 of 2,200, newest first